Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC Map: A prospective large-scale cohort study

Journal of Magnetic Resonance Imaging

Volumn 35, Issue 6, 2012, Pages 1414-1421

  Watanabe, Yuji ^a   Terai, Akito ^a   Araki, Tohru ^b   Nagayama, Masako ^a   Okumura, Akira ^a   Amoh, Yoshiki ^a   Ishimori, Takayoshi ^a   Ishibashi, Mana ^a   Nakashita, Satoru ^a   Dodo, Yoshihiro ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

^b Araki Urology Clinic   (Japan)

Author keywords

apparent diffusion coefficient; diffusion weighted imaging; magnetic resonance imaging; prostate cancer; targeted biopsy; transition zone

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT MAP; CANCER DIAGNOSIS; CANCER LOCALIZATION; COHORT ANALYSIS; DIAGNOSTIC PROCEDURE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FALSE NEGATIVE RESULT; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REVIEW; TARGETED BIOPSY;

AGED; BIOPSY, NEEDLE; COHORT STUDIES; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; JAPAN; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; PREVALENCE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84862103102     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23587     Document Type: Review

References (26)

1. Delongchamps NB, Haas GP,. Saturation biopsies for prostate cancer: current uses and future prospects. Nat Rev Urol 2009; 6: 645-652.
2. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J,. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006; 175: 1605-1612.
3. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL,. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000; 163: 158-162.
4. Pryor MB, Schellhammer PF,. The pursuit of prostate cancer in patients with a rising prostate-specific antigen and multiple negative transrectal ultrasound-guided prostate biopsies. Clin Prostate Cancer 2002; 1: 172-176. (Pubitemid 37012398)
5. Delongchamps NB, de la Roza G, Jones R, Jumbelic M, Haas GP,. Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer. BJU Int 2009; 103: 49-54.
6. Haas GP, Delongchamps NB, Jones RF, et al. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst 2007; 99: 1484-1489.
7. Wright JL, Ellis WJ,. Improved prostate cancer detection with anterior apical prostate biopsies. Urol Oncol 2006; 24: 492-495. (Pubitemid 44810011)
8. Bott SR, Young MP, Kellett MJ, Parkinson MC,. Anterior prostate cancer: is it more difficult to diagnose? BJU Int 2002; 89: 886-889. (Pubitemid 34535421)
9. Mullerad M, Hricak H, Kuroiwa K, et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 2005; 174: 2158-2163. (Pubitemid 41611764)
10. Claus FG, Hricak H, Hattery RR,. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 2004; 24 (Suppl 1): S167-S180. (Pubitemid 39457252)
11. Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000; 164: 400-404. (Pubitemid 30481935)
12. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006; 239: 784-792. (Pubitemid 43830614)
13. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL,. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis - correlation with biopsy and histopathology. J Magn Reson Imaging 2006; 24: 108-113.
14. Tamada T, Sone T, Toshimitsu S, et al. Age-related and zonal anatomical changes of apparent diffusion coefficient values in normal human prostatic tissues. J Magn Reson Imaging 2008; 27: 552-556. (Pubitemid 351354740)
15. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S,. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007; 25: 146-152. (Pubitemid 46095209)
16. Ishida J, Sugimura K, Okizuka H, et al. Benign prostatic hyperplasia: value of MR imaging for determining histologic type. Radiology 1994; 190: 329-331. (Pubitemid 24044228)
17. Yoshimitsu K, Kiyoshima K, Irie H, et al. Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J Magn Reson Imaging 2008; 27: 132-139.
18. Ellis WJ, Chetner MP, Preston SD, Brawer MK,. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J Urol 1994; 152: 1520-1525. (Pubitemid 24326300)
19. Jones JS, Patel A, Schoenfield L, Rabets JC, Zippe CD, Magi-Galluzzi C,. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 2006; 175: 485-488. (Pubitemid 43067334)
20. Descazeaud A, Rubin M, Chemama S, et al. Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen. World J Urol 2006; 24: 676-680. (Pubitemid 44896709)
21. Nagayama M, Watanabe Y, Terai A, et al. Determination of the cut-off level of apparent diffusion coefficient values in the detection of prostate cancer. Jpn J Radiol 2011; 29: 488-494.
22. Mazaheri Y, Hricak H, Fine SW, et al. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. Radiology 2009; 252: 449-457.
23. Singh AK, Kruecker J, Xu S, et al. Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int 2008; 101: 841-845. (Pubitemid 351347719)
24. Epstein JI, Walsh PC, Carmichael M, Brendler CB,. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368-374. (Pubitemid 24037911)
25. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP,. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71: 933-938. (Pubitemid 23049614)
26. Galper SL, Chen MH, Catalona WJ, Roehl KA, Richie JP, D'Amico AV,. Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. J Urol 2006; 175: 907-912. (Pubitemid 43200015)